Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

about

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

Item

http://www.wikidata.org/entity/Q39224343

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@en

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@nl

type

Item

label

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@en

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@nl

prefLabel

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@en

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@nl

P1476

Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

@en

P2093

Amary Alcide

http://www.w3.org/2001/XMLSchema#string

Janice O'Driscoll

http://www.w3.org/2001/XMLSchema#string

Tan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults

Role of apolipoprotein E in anxiety

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature

Impact of APOE in mild cognitive impairment

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.

The role of GABA in anxiety disorders.

Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease.

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice.

Predictors of progression from mild cognitive impairment to Alzheimer disease.

P304

1312-1321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GPS.4614

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shanna L Burke

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27805724

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5441966

http://www.w3.org/2001/XMLSchema#string